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Changes in high localised concentrations of Ca2þ ions are fundamental to cell signalling. The synthesis of
a dual excitation, ratiometric calcium ion sensor with a Kd of 90 mM, is described. It is tagged with an
azido group for bioconjugation, and absorbs in the blue/green and emits in the red region of the visible
spectrum with a large Stokes shift. The binding modulating nitro group is introduced to the BAPTA core
prior to construction of a benzofuran-2-yl carboxaldehyde by an allylationeoxidationecyclisation se-
quence, which is followed by condensation with an azido-tagged thiohydantoin. The thiohydantoin unit
has to be protected with an acetoxymethyl (AM) caging group to allow CuAAC click reaction and in-
corporation of the KDEL peptide endoplasmic reticulum (ER) retention sequence.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Free Ca2þ is an important cell messenger involved in numerous
processes such as muscle contraction, cell division and cell death.1
The effects of changing the Ca2þ concentration, [Ca2þ], can have
a wide reach, extending both within and among cells.1 [Ca2þ] can
also affect a range of different activities by acting selectively as
a highly localised signal operating in subcellular regions. The free
cytosolic [Ca2þ] is typically in the region of 100 nM at rest and in-
creases to an averaged peak cellular value of<1 mMwhen the cell is
activated.2 However, to selectively performmultiple functions, cells
localise signals to certain regions by creating high local [Ca2þ] in the
range of tens to several hundred micromolar.3 These localised
concentrations of Ca2þ enable the control of specific cellular ac-
tivities, such as ion channel and transcription factor activation. In
addition to high local concentrations in the cytoplasm, organelles
such as the mitochondria, sarcoplasmic reticulum, endoplasmic
reticulum and Golgi apparatus each store Ca2þ at concentrations
(hundreds of micromolar) far above the cytoplasmic average.4
Understanding of how [Ca2þ] selectively controls cell function re-
mains preliminary because of the difficulties in studying Ca2þ sig-
nals in specific cell regions. Therefore, there have been efforts to.Hartley@glasgow.ac.uk (R.C.
r Ltd. This is an open access articldevelop sensors to study localised and dynamic calcium
concentrations.5e7
As part of these efforts, we set out to develop a fluorescent
sensor that would detect changes in the high [Ca2þ] found in sub-
cellular stores. We wanted a sensor that absorbed and emitted in
the visible rather than UV region of the spectrum so that its use
would disturb the system minimally, and that was ratiometric so
that quantification was straightforward. Above all, we wanted to
incorporate a tag so that bioorthogonal chemistry could be used to
attach a targeting group or to attach the sensor to biomolecules.
We chose to develop a sensor using the highly selective octa-
dentate binding of the Ca2þ ion by a 1s,2-bis(ortho-aminophenoxy)
ethane-N,N,N0,N’-tetraacetic acid (BAPTA) ligand,8,9 which has be-
come a powerful tool for studying changes in [Ca2þ].10e18 Recent
work has focused on developing sensors that absorb and emit in the
low-energy red and near infrared regions of the spectrum,14e17
both to limit damage and to allow the use of several different flu-
orophores in the same sample (multiplexing).18 In linewith this, we
decided that our BAPTA-based sensor should absorb and emit in the
red region of the spectrum.
We considered an ideal Ca2þ sensor would be fluorescent both
with Ca2þ bound and in its unbound state, but with different ab-
sorption or emission wavelengths. This would allow the [Ca2þ] to
be determined directly using the ratio of the two forms using the
binding dissociation constant of the sensor (Kd). The use of such so-
called ratiometric probes offers many advantages over traditionale under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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and variation in probe loading.19 However, the development of
ratiometric Ca2þ sensors has lagged behind the development of the
traditional off/on probes. Indeed, most biological studies using this
technique20,21 rely on the original two sensors, Fura-2 and Indo-
1,8,9 which both absorb in the UV region of the spectrum. There are
recent promising ratiometric probes developed by Liu et al.,13 but
the area is underdeveloped. On the other hand, we and a few others
have used Fura-Red22,23 as a ratiometric Ca2þ sensor that is excited
by visible light. It is a dual excitation ratiometric probe so that
[Ca2þ] can easily be determined from the ratio of the emissions at
640 nm when excited at 436 nm (Ca2þ-bound sensor) and when
excited at 472 nm (free sensor).23 Fura-Red’s very large Stokes shift
ofw200 nm also allows the simultaneous use of other dyes such as
Fluo-4.24
Given these excellent properties of Fura-Red, we decided to
adjust its binding affinity so that it could detect changes when
[Ca2þ] is high. The binding dissociation constant (Kd) should be
midway between the starting and final [Ca2þ] in the process under
study to maximise the observable response of the sensor. Most of
the commonly-used Ca2þ sensors have Kd values within the
nanomolar range (e.g., Fura-Red has a Kd¼380 nM22,25), which
makes them suitable for measuring global cytosolic [Ca2þ]
fluxes.10,11 We reasoned that a low affinity Fura-Red derivative,
NitroAzidoFuraRed (Fig. 1), could be prepared that would have an
azido tag for bioorthogonal chemistry.26O O
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Fig. 1. The design of NitroAzidoFuraRed.
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Scheme 1.Fura-Red’s fluorescent properties arise from photoinduced
charge transfer because the fluorophore is in direct conjugation
with the BAPTA unit and that conjugation changes when the ni-
trogen lone pair turns out of plane during binding.18 We reasoned
that the binding affinity would be decreased by incorporating an
electron-withdrawing group on the A ring, which would increase
the conjugation with the amino group.18 This in turn would dis-
favour the rotation out of plane that is required for binding to Ca2þ
and so lower the binding affinity, raising Kd.11 We wished to gen-
erate a ratiometric probe with a Kd in the 50e100 mM range that
could be used to investigate intra-organellar [Ca2þ]. Having con-
sidered the binding affinities of known Ca2þ sensors10,11,27 and
correlations with Hammett s constants,28 we decided to in-
corporate a nitro group in the BAPTA core.29We also decided to incorporate an azido tag in Nitro-
AzidoFuraRed because it would offer a universal site of attachment
by bioorthogonal chemistry26 that could be used to incorporate
a targeting group or biomolecule using copper-catalysed or strain-
promoted azideealkyne cycloaddition (CuAAC16,27,30 or SPAAC31).
The azido group would be attached through the thiohydantoin unit
so that it would be distal from the BAPTA binding site to minimise
potential interference with Ca2þ binding.16,27,30,31
In summary, we had designed NitroAzidoFuraRed to be a low-
affinity, ratiometric, Ca2þ sensor excitable with visible light and
displaying a large Stokes shift, which would have the potential for
attachment to targeting groups and biomolecules. Herein, we show
how it was synthesised and present its calcium ion binding prop-
erties. We also provide the first examples of CuAAC on thio-
hydantoin derivatives.
2. Results and discussion
There have been no published syntheses of low affinity Fura-Red
indicators. Our approach was to construct the BAPTA core 8 by
adapting the route of Grynkiewicz et al.9 Starting from hydroqui-
none 1, benzyl protection gave bisether 2, which was then con-
verted into the nitro derivative 3. Selective deprotection of the
ortho-benzyl group was achieved using aluminium trichloride in-
stead of TFA to give phenol 4 in good yield.32 Coupling phenol 4
with known bromide 6, prepared from phenol 5,33 gave bis-nitro
compound 7 in quantitative yield. Reduction of the nitro groups
in the presence of the benzyl ether was achieved using iron rather
Fig. 2. Absorption (solid line) and emission (dashed line) maxima of Ca2þ-free 43 mM
NitroAzidoFuraRed (red) and Ca2þ saturated NitroFuraRed (blue) normalised to 1.0.
Emission spectra were obtained by excitation at absorption maxima at 465 nm (red)
and 440 nm (blue), respectively.
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S.T. Caldwell et al. / Tetrahedron 71 (2015) 9571e9578 9573than Pt/H2. The use of acetone as a co-solvent was necessary for
solubility and critical to the success of this reaction. The resulting
diamine was then alkylated to give the tetraethyl ester 8 in excel-
lent yield.
Selective formylation of the more electron rich ring gave alde-
hyde 10, which was deprotected by hydrogenolysis to yield phenol
11. Construction of the benzofuran unit by alkylation with the
diethyl acetal of bromoacetaldehyde followed by acid-induced
cyclisation34 proved capricious, so we decided to investigate ally-
lation of the phenol, followed by oxidative cleavage and cyclisation.
This route to benzofuran-2-ylcarboxaldehydes is new and there
was only one literature example35 of an allyl group being cleaved in
the presence of a tertiary amine. The literature example employed
ozonolysis, but the use of osmium tetroxide/sodium periodate
followed by acid proved satisfactory. Nitration of the A ring has to
be carried out after construction of the BAPTA unit and deactivation
of the B ring by the aldehyde to take advantage of the directing
effect of the amino group,14,29,36 and experimentation showed that
it was best performed on the allyl ether 12. Oxidation of the
nitrated compound 13 and cyclisation then gave the desired ben-
zofuran 14 in modest yield over the two steps (Scheme 1).
The final part of the synthesis required the incorporation of the
thiohydantoin unit (Scheme 2). 3-Azidopropylamine 15 was pre-
pared by the literature method,37 converted into an isothiocyanate
and reacted with the methyl ester of glycine to give thiohydantoin
16.38 Knoevenagel condensation39 with aldehyde 14 completed the
fluorophore 17 and saponification of the esters gave
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from 0 mM to 2000 mM. The excitation bandpass was 5 nm and fluorescence emission
collected at 630 nm (bandpass 30 nm). The spectra have been corrected for back-
ground fluorescence. 5 mM NitroAzido-FuraRed in a 100 mM KCl, 30 mM MOPS, pH 7.2
buffer was incrementally exposed to rising [Ca2þ] from 0 to 2 mM. With increasing
[Ca2þ], fluorescence emission decreases with excitation above 452 nm and increases
with excitation below 452 nm (arrows are drawn at 420 nm and 485 nm).
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Scheme 3.With the desired compound in hand we next investigated the
optical properties of the new sensor. As expected, the UV/Vis ab-
sorption spectra of the Ca2þ free and Ca2þ bound Nitro-
AzidoFuraRed are very similar to Fura-Red showing aw25 nm blue
shift in the absorption maximum upon Ca2þ binding (Fig. 2). The
fluorescence spectra of the Ca2þ free and Ca2þ bound Nitro-
AzidoFuraRed are also like Fura-Red showing the expected emis-
sion maximum at w630 nm.
Having established that the probe possessed the desired optical
properties, we turned our attention to the binding properties. The
excitation spectra of NitroAzidoFuraRed were obtained with dif-
ferent concentrations of Ca2þ and showed a good isobestic point at
452 nm (Fig. 3). The Kd of the probe was found to be 90 mM using
this titration and the ratio of fluorescence intensities at 630 nm
when excited at 420 nm and 485 nm, following the method of
Grynkiewitz et al.9With a sensor with desirable properties in hand, we tested the
conjugation reaction. A model thiohydantoin derivative 18, pre-
pared from thiohydantoin 16, was used to test the CuAAC with
alkyne-tagged phenylalanine derivative 20 (Scheme 3). However,
mixtures immediately turned red upon mixing the thiohydantoin
S.T. Caldwell et al. / Tetrahedron 71 (2015) 9571e95789574with copper(I) ions and the click reaction was ineffective. This is
consistent with the reported formation of a thiohydantoin-copper
complex.40 The tetracarboxylate BAPTA-based fluorophores are
cell-impermeable and are generally caged as acetoxymethyl (AM)
esters so that they can cross the plasmamembrane.41 The AM esters
are hydrolysed rapidly by esterases inside cells to give the active
Ca2þ sensors. This strategy has been used for FuraRed,11 which also
includes N-acetylmethyl caging of the thiohydantoin group. Since
NitroAzidoFuraRed is designed to be used in cells, we investigated
whether AM-protection of the model thiohydantoin would allow
CuAAC. Happily, conversion of thiohydantoin 18 into the AM de-
rivative 19 was followed by smooth CuAAC to give the triazole
adduct 21, a process that occurred without the dramatic colour
change observed previously.
We then decided to illustrate the conjugation reaction for
NitroAzidoFuraRed itself. Proteins to be retained in the endoplas-
mic reticulum (ER) of cells carry the peptide KDELmotif so that they
are recovered from other parts of the cell and returned to the ER.42
Inclusion of this retention sequence has been used as a way of
localising compounds and nanoparticles in the ER.43 Therefore, we
exemplified the conjugation of NitroAzidoFuraRed by AM pro-
tection followed by CuAAC with an FFKDEL peptide functionalised
at the N-terminus as the amide of 4-pentynoic acid. Under the
conditions tested above, this gave the penta-AM protected triazole
in 42% yield.
3. Conclusion
In conclusion, we have prepared a Ca2þ sensor that is ratio-
metric, absorbs and emits at long wavelength, has a large Stokes
shift, is tuned to low affinity for detection of changes in [Ca2þ] in
intracellular stores and has an azido tag for conjugation to allow
localisation in cells. Nitration to introduce the binding-modulator
had to be carried out after the synthesis of the BAPTA unit and
the introduction of an electron-withdrawing aldehyde, but before
introducing the benzofuran moiety. The benzofuran was then
constructed using a novel allylationeoxidationecyclisation. Finally,
the azido-tagged thiohydantoin was introduced by Knoevenagel
reaction. We then demonstrated the first CuAAC of a thiohydantoin
derivative, showing that AM protection is critical to its success, and
demonstrated its potential in bioconjugation by attaching an
FFKDEL peptide, which incorporates the ER protein retention
sequence.
4. Experimental section
4.1. General
All reactions under an inert atmosphere were carried out using
oven-dried or flame dried glassware. Solutions were added via
syringe. Dichloromethane and acetonitrile were dried where nec-
essary using a solvent drying system, Puresolv TM, inwhich solvent
is pushed from its storage container under low nitrogen pressure
through two stainless steel columns containing activated alumina
and copper. Reagents were obtained from commercial suppliers
and used without further purification unless otherwise stated.
Flash column chromatography was carried out using Fisher matrix
silica 60 or using a Biotage Isolera one automated system. 1H and
13C NMR spectra were obtained on a Bruker AVIII/500 spectrometer
operating at 500 and 125 MHz, respectively or a Bruker AVIII/400
spectrometer operating at 400 and 100 MHz, respectively. All
coupling constants aremeasured in Hz. DEPTwas used to assign the
signals in the 13C NMR spectra as C, CH, CH2 or CH3. EI and CI mass
spectra were obtained using the (M Station) JEOL JMS-700 spec-
trometer. ESI spectra were collected on a Bruker MicroTOF-Q. Infra-
red (IR) spectra were obtained on a Shimadzu FTIR-8400Sspectrometer using attenuated total reflectance (ATR) so that the
IR spectrum of the compound (solid or liquid) could be directly
detected (thin layer) without any sample preparation.
4.2. Experimental procedures
4.2.1. 1,4-Bis(benzyloxy)benzene 2.31 1,4-Hydroquinol 1 (40.0 g,
363 mmol, 1.00 equiv) and benzyl chloride (101 ml, 878 mmol,
2.42 equiv) were suspended in ethanol (268 ml). Ethanolic KOH
(250 ml, 2.85 M) was added and the mixture stirred mechanically
for 3 h under argon then allowed to stand for 3 days. The mixture
was quenched in H2O and the off-white precipitate was filtered and
crystallised in eight portions (14 g/500 ml) from boiling EtOH. The
combined crystallisation leftovers were combined, then concen-
trated to give another crop of crystals. The combined solid was
dried under vacuum to give ether 2 as needles (71.8 g, 68%). dH
(400 MHz, CDCl3): 7.45e7.28 (10H, m, OCH2Ph), 6.90 (4H, s,
Ph(OBn)2), 5.01 (4H, s, OCH2Ph). 13C NMR (101MHz, CDCl3) d 153.26
(C), 137.37 (C), 128.68 (CH), 128.02 (CH), 127.60 (CH), 115.90 (CH),
70.74 (CH2). Spectroscopic data agree with lit.31
4.2.2. 1,4-Bis(benzyloxy)-2-nitrobenzene 3.31 Nitric acid (70%)
(19.5 ml, 437.4 mmol, 2.0 equiv) was added slowly to a suspension
of hydroquinol 2 (63.5 g, 218.7mmol,1.0 equiv) in glacial acetic acid
(400 ml) at 0 C. The solutionwas stirred at 0 C for 3 h, poured into
water (w1500 ml) and the resulting precipitate filtered off. The
precipitate was washed with water (1500 ml), dissolved in CHCl3
(300 ml), dried over magnesium sulfate and concentrated under
vacuum to give nitro compound 3 as a yellow solid. (73.04 g, 100%).
mp 80e81 C (lit.: 80e81 C44). dH (400 MHz, CDCl3): 7.49 (1H, d,
J¼3.0, H3), 7.46e7.30 (10H, m, OCH2Ph), 7.12 (1H, dd, J¼9.2, 3.1 Hz,
H5), 7.05 (1H, d, J¼9.2 Hz, H6), 5.18 (2H, s, CH2), 5.05 (2H, s, CH2). 13C
NMR (101 MHz, CDCl3) d 152.30 (C), 146.39 (C), 135.97 (C), 135.88
(C), 128.75 (CH), 128.70 (CH), 128.37 (CH), 128.22 (CH), 127.59 (CH),
127.15 (CH), 121.54 (CH), 117.24, 111.18 (CH), 72.10 (CH2), 70.94
(CH2). IR (ATR cm1): 1520 (NO2), 1497 (CAr]CAr), 1341 (NO2). MS
(ESIþ): 358 [(MþNa)þ, 100]. HRMS: 358.1034. C20H17NNaO4 re-
quires 358.1050. Spectroscopic data agree with lit.31
4.2.3. 4-Benzyloxy-2-nitrophenol 4.31 Nitroaryl 3 (4.50 g,
13.4 mmol, 1.00 equiv) was dissolved in CHCl3 (65ml) and stirred at
0 C under argon. To the mixture a suspension of AlCl3 (2.07 g,
15.5mmol,1.16 equiv) in CHCl3 (10ml) was added portionwisewith
additional CHCl3 (20 ml). The reaction was monitored by TLC and
was complete after 15 min. The mixture was quenched into HCl(aq)
(1 M) and extracted with DCM ( 3). The combined organics were
dried (MgSO4), filtered and the solvent removed under reduced
pressure. The residue was crystallised from boiling MeOH, then
recrystallised from boiling MeOHwith 5% H2O added. The resulting
crystals were washed (H2O), then partitioned between H2O and
DCM. The organic layer was separated and the solvent removed
under reduced pressure, giving nitrophenol 4 as a solid (1.88 g,
57%). dH (400MHz, CDCl3): 10.36 (1H, s, ArOH), 7.61 (1H, d, J¼3.1 Hz,
H3), 7.46e7.33 (5H, m, OCH2Ph), 7.29 (1H, dd, J¼9.2, 3.1 Hz, H5), 7.10
(1H, d, J¼9.2 Hz, H6), 5.06 (2H, s, PhCH2). 13C NMR (101MHz, CDCl3)
d 151.64 (C), 150.20 (C), 135.86 (C), 132.97 (C), 128.76 (CH), 128.42
(CH),127.88 (CH),127.65 (CH), 120.93 (CH), 107.19 (CH), 70.92 (CH2).
IR ymax (ATR)/cm1: 3231 (OeH), 3123 (CAr-H), 3106 (CAr-H), 1584
(CAr]CAr), 1530 (NO2), 1501 (CAr]CAr), 1485 (CAr]CAr), 1316 (NO2).
MS (EIþ): 245 (Mþ, 18%), 91 (C7H7þ, 100). HRMS: 245.0696.
C13H11O4N requires 245.0688. Spectroscopic data agree with lit.31
4.2.4. 1-(2-Bromoethoxy)-2-nitrobenzene 6.33 2-Nitrophenol 5
(3.99 g, 28.7 mmol, 1.00 equiv), 1,2-dibromoethane (7.5 ml,
87 mmol, 3.0 equiv) and K2CO3 (4.36 g, 31.6 mmol, 1.10 equiv) were
combined in DMF (6.0 ml) and stirred at 120 C for 3 h under argon.
S.T. Caldwell et al. / Tetrahedron 71 (2015) 9571e9578 9575The precipitate was filtered off and washed with DCM and H2O. The
filtrate layers were separated and the organics were washed with
0.5 M NaOH(aq) and saturated brine solution. The organics were
dried (MgSO4) and filtered, then the solvent was removed under
reduced pressure to give the bromide 6 (4.53 g, 65%) as a solid. mp
36e40 C (lit.: 36e38 C45).dH (400 MHz, CDCl3): 7.85 (1H, dd,
J¼8.3, 1.7 Hz, H6), 7.55 (1H, ddd, J¼8.4, 7.5, 1.7 Hz, H4), 7.12e7.06
(2H, m, H3, H5), 4.42 (2H, t, J¼6.5 Hz, OCH2CH2Br), 3.68 (2H, t,
J¼6.5 Hz, OCH2CH2Br). Data agree with lit.33
4.2.5. 2-Nitro-1-[20-(400-benzyloxy-200-nitrophenoxy)ethoxy]benzene
7. 1-(2-Bromoethoxy)-2-nitrobenzene 6 (10.9 g, 44.3 mmol,
1.47 equiv), nitrophenol 4 (7.0 g, 30 mmol, 1.0 equiv) and K2CO3
(3.0 g, 22mmol, 0.7 equiv) were combined in dry DMF (17.0 ml) and
stirred at 140 C for 2 h under argon, then allowed to stir at rt for
12 h. The material was heated to 50 C, and the precipitate was
dissolved with dropwise addition of water. After 24 h stirring
precipitate had formed and was collected by filtration. The material
was then washed out in a mixture of acetone and hexane. The
solvent was removed under reduced pressure and the compound
dissolved in DCM then washed with water ( three) and 5% LiCl(aq)
solution, then the solvent removed from the combined organics to
give the ether 7 in quantitative yield (12.4 g, quant). mp 110e111 C.
dH (400 MHz, CDCl3): 7.84 (1H, dd, J¼8.1, 1.7 Hz, H-3), 7.57 (1H, ddd,
J¼8.5, 7.4, 1.7 Hz, H-5), 7.47e7.32 (6H, m, OCH2Ph, H-300), 7.23e7.19
(3H, m, H6, H500, H600), 7.12e7.05 (1H, m, H4), 5.07 (2H, s, OCH2Ph),
4.52e4.46 (4H, m, OCH2CH2O). dC (CDCl3, 100 MHz): 152.95 (C),
151.956 (C), 146.37 (C), 140.63 (C), 140.20 (C), 135.90 (C), 134.34
(CH), 128.76 (CH), 128.38 (CH), 127.59 (CH), 125.68 (CH), 121.73
(CH), 121.24 (CH), 118.75 (CH), 115.61 (CH), 111.04 (CH), 70.96 (CH2),
69.99 (CH2), 68.77 (CH2). ymax (ATR)/cm1: 3094 (CH), 2960 (CH),
2929 (CH), 2871 (CH), 1606 (CAr]CAr), 1518 (NO2), 1497 (CAr]CAr),
1487 (NO2), 1451 (CAr]CAr). MS (EIþ): (410 Mþ., 45%), 166
(O2NC6H4OCH2CH2þ, 38), 122 (C4H4NO2þ, 44), 91 (PhCH2þ, 100).
HRMS: 410.1114. C21H18N2O7 requires Mþ 410.1114.
4.2.6. 2-[20-(200-Aminophenoxy)ethoxy]-5-(benzyloxy)aniline 8. Iron
powder (8.44 g, 151.13 mmol, 7.7 equiv) was added portionwise to
a solution of dinitro compound 7 (8.05 g,19.61mmol,1.0 equiv) and
ammonium chloride (6.47 g, 121.04 mmol, 6.17 equiv) in acetone:
water (300ml (4:1)). The suspensionwas stirred rapidly and heated
to 70 C under argon overnight. After cooling to rt the mixture was
filtered through Celite eluting with acetone, the solvent was re-
moved under reduced pressure. The residue was dissolved in DCM,
filtered through Celite again eluting with dichloromethane. The
dichloromethane layer was washed with brine, dried (MgSO4), fil-
tered and the solvent removed under reduced pressure to give di-
amine 8 as a solid (6.23 mg, 91%). mp 146 C. dH (400 MHz, CDCl3):
7.44e7.34 (4H, m, H2000, H3000, H5000, H6000) 7.33e7.27 (1H, m, H4000),
6.86e6.79 (2H, m, H400, H600), 6.77 (1H, d, J¼8.7 Hz, H3), 6.74e6.68
(2H, m, H300, H500), 6.39, (1H, d, J¼2.9 Hz, H6), 6.30 (1H, dd, J¼8.7,
2.9 Hz, H5), 4.98 (2H, s, OCH2Ph), 4.35e4.27 (4H, m, OCH2CH2O),
3.83 (4H, s, NH2). dC (100MHz, CDCl3): 154.37 (C), 146.26 (C), 140.85
(C), 138.24 (C), 137.47 (C), 136.89 (C), 128.52 (CH), 127.81 (CH),
127.43 (CH), 121.94 (CH), 118.38 (CH), 115.36 (CH), 114.31 (CH),
112.66 (CH), 103.46 (CH), 103.10 (CH), 70.43 (CH2), 68.64 (CH2),
67.64 (CH2). IR (ATR cm1): 3454 (NH), 3433 (NH), 3367 (NH), 3350
(NH), 3063 (CAreH), 3038 (CAreH), 2959 (CeH), 2939 (CeH), 2886
(CeH), 1611 (CAr]CAr), 1601 (CAr]CAr), 1595 (CAr]CAr), 1207
(CeO). MS (EIþ): 350 (Mþ, 70%), 241 (MþeC6H4NH2O, 9), 215
(C13H13NO2þ, 42), 214 (C13H14NO2þ, 11), 136 (C8H9NOþ, 41), 91 (C7H7þ,
100). HRMS: 350.1629 requires 350.1630.
4.2.7. Ethyl 2-N-(200-{2000-[4000 0-(benzyloxy)-20000-N,N-(2000 00-ethoxy-
2000 00-oxoethyl)amino]phenoxy]ethoxy}phenyl)-N-(20-ethoxy-20-ox-
oethyl)amino]acetate 9. Aniline 8 (1.80 g, 5.14 mmol, 1.00 equiv)was dried by azeotrope twice in PhMe then combined under argon
with NaI (2.12 g, 14.1 mmol, 2.75 equiv, dried under vacuum at
100 C for 6 h) and proton sponge (also dried by azeotrope in PhMe,
7.50 g, 35.0 mmol, 6.81 equiv) dry MeCN (10.0 ml) and ethyl bro-
moacetate (5.00 ml, 46.3 mmol, 9.01 equiv) were added to the
stirring mixture which was then heated under reflux for 24 h. The
solvent was then removed under reduced pressure and the residue
was dissolved in PhMe and filtered. The filtrate was washed five
times with dilute HCl(aq), then the organics were then combined
and the solvent removed under vacuum. Crystallisation (Pet. ether/
EtOAc) gave the diamine tetraester 9 (4.00 g, quant.) as needles. mp
96e97 C. dH (400 MHz, CDCl3): 7.45e7.34 (4H, m, H2000 00, H3000 00,
H5000 00, H6000 00) 7.33e7.28 (1H, m, H4000 00), 6.93e6.78 (4H, m, H300, H400,
H500, H600), 6.76 (1H, d, J¼9.5 Hz, H6000 0), 6.50e6.44 (2H, m, H3000 0,
H5000 0), 4.97 (2H, s, OCH2Ph), 4.23 (4H, s, OCH2CH2O), 4.16 (4H, s,
NCH2), 4.14 (4H, s, NCH2), 4.055 (4H, q, J¼7.2 Hz, CO2CH2), 4.053
(4H, q, J¼7.2 Hz, CO2CH2), 1.16 (6H, t, J¼7.1 Hz, CH2CH3), 1.15 (6H, t,
J¼7.1 Hz, CH2CH3). dC (100 MHz, CDCl3): 171.60 (C), 171.42 (C),
153.61 (C), 150.32 (C), 144.73 (C), 140.58 (C), 139.36 (C), 137.22 (C),
128.53 (CH), 127.89 (CH), 127.53 (CH), 122.13 (CH), 121.40 (CH),
118.96 (CH), 114.43 (CH), 113.09 (CH), 107.22 (CH), 106.37 (CH),
70.45 (CH2), 67.81 (CH2), 67.11 (CH2), 60.80 (CH2), 60.75 (CH2),
53.49 (CH2), 53.44 (CH2), 14.06 (CH3), 14.03 (CH3). IR ymax (ATR)/
cm1: 2986 (CAr]CAr), 2932b (CAr]CAr), 1736 (CO),1598 (CAr]CAr),
1512 (CAr]CAr). MS (NSI): 717 [(MþNaþ), 52%], 695 [(MþH)þ, 100].
HRMS: 695.3173. C37H47O11N2 requires 695.3180.
4.2.8. Ethyl 2-[(200-{2000-[4000 0-(benzyloxy)-2000 0-[bis(2000 00-ethoxy-2000 00-
oxoethyl)amino]5-formylphenoxy]ethoxy}phenyl) (20-ethoxy-20-ox-
oethyl)amino]acetate 10. Phosphorus oxychloride (6.0 ml,
64.94 mmol, 8.0 equiv) was added slowly to a solution of tetraester
9 (5.64 g, 8.11 mmol, 1.00 equiv) and pyridine (6.54 ml, 81.1 mmol,
10.0 equiv) in DMF (40 ml) at 0 C under argon. The resulting red
solutionwas stirred at 0 C for 1.5 h then slowly quenchedwith cold
KOH solution (1M). The solution was extracted in dichloromethane
(370 ml), the combined organic layers were washed with brine
(4200 ml) dried over magnesium sulfate and concentrated under
vacuum to give the aldehyde suitably pure to use without further
purification (5.60 g, 95%). mp 135e136 C. dH (400 MHz, CDCl3):
10.31 (1H, s, CHO) 7.42e7.31 (5H, m, Ph), 7.29 (1H, s, H6000 0),
6.93e6.79 (4H, m, H300, H400, H500 H600), 6.30 (1H, s, H3000 0), 5.10 (2H, s,
OCH2Ph), 4.27e4.20 (4H, m, OCH2CH2O), 4.18 (4H, s, NCH2), 4.14
(4H, s, NCH2), 4.06 (4H, q, J¼7.1 Hz, CO2CH2), 4.03 (4H, q, J¼7.1 Hz,
CO2CH2), 1.16 (6H, t, J¼7.2 Hz, CH2CH3), 1.14 (6H, t, J¼7.1 Hz,
CH2CH3). dC (100 MHz, CDCl3): 187.49 (CH), 171.51 (C), 170.7051 (C),
157.34 (C), 150.19 (C), 146.44 (C), 143.96 (C), 139.48 (C), 136.32 (C),
128.71 (CH), 128.24 (CH), 127.29 (CH), 122.10 (CH), 121.66 (CH),
119.10 (CH), 117.98 (C), 113.32 (CH), 110.62 (CH), 102.67 (CH), 71.10
(CH2), 67.61 (CH2), 66.90 (CH2), 61.22 (CH2), 60.76 (CH2), 53.86
(CH2), 53.50 (CH2), 14.07 (CH3), 14.02 (CH3). IR (ATR cm1): 2975
(CAreH), 2938 (CAreH), 2928 (CAreH), 2873 (CAreH), 1745 (CO),
1718 (CO), 1662, 1598 (CAr]CAr), 1517 (CAr]CAr), 1508 (CAr]CAr).
MS (NSI): 1462 [(2MþNH4þ), 6%], 761 [(MþKþ), 3], 745 [(MþNaþ),
60], 740 [(MþNH4þ), 45], 723 [(MþHþ), 100]. HRMS: 723.3121 re-
quires 723.3129, C38H47O12N2.
4.2.9. Ethyl 2-{[200-(2000-{2000 0-[bis(200000-ethoxy-200000-oxoethyl)amino]-
5000 0-formyl-4000 0-hydroxyphenoxy}ethoxy)phenyl](20-ethoxy-20-ox-
oethyl)amino}acetate 11. Palladium on carbon (10% loading by
weight, 600 mg) was added to a solution of aldehyde 10 (2.04 g,
2.82 mmol, 1.00 equiv) in acetic acid (30 ml). The suspension was
flushed with H2(g) then stirred under a H2(g) atmosphere overnight.
After this time, the solution was filtered through Celite and the
Celite washed with EtOAc. The combined organic solvents were
concentrated under vacuum. Any residual acetic acid was removed
by toluene azeotrope to give phenol 11 as an off white solid. (1.75 g,
S.T. Caldwell et al. / Tetrahedron 71 (2015) 9571e9578957698%). mp 78e80 C. dH (400 MHz, CDCl3): 11.21 (1H, s, PhOH), 9.61
(1H, s, CHO), 6.92 (1H, s, H60000), 6.94e6.82 (4H, m, H300, H400, H500
H600), 6.15 (1H, s, H3000 0), 4.23 (4H, s, OCH2CH2O), 4.22 (4H, s, NCH2),
4.15 (4H, s, NCH2), 4.08 (4H, q, J¼7.1 Hz, CO2CH2), 4.08 (4H, q,
J¼7.1 Hz, CO2CH2), 1.19 (6H, t, J¼7.2 Hz, CH2CH3), 1.16 (6H, t,
J¼7.2 Hz, CH2CH3). dC (100 MHz, CDCl3): 193.22 (CH), 171.49 (C),
170.37 (C), 158.82 (C), 150.17 (C), 148.32 (C), 142.72 (C), 139.48 (C),
122.25 (CH), 121.78 (CH), 119.23 (CH), 115.90 (CH), 113.38 (CH),
113.06 (C), 104.22 (CH), 68.23 (CH2), 66.92 (CH2), 61.34 (CH2), 60.78
(CH2), 53.85 (CH2), 53.48 (CH2),14.09 (CH3),13.97 (CH3). ymax (ATR)/
cm1: 2977 (CAreH), 2960 (CAreH), 2937 (CAreH), 2908 (CAreH),
2877 (CAreH), 1739 (CO), 1630 (CO), 1507 (CAr]CAr). MS (NSI): 671
[(MþKþ), 5%], 655 [(MþNaþ), 62], 650 [(MþNH4þ), 22], 633
[(MþHþ), 100]. HRMS: 633.2652. (MþH)þ C31H41O12N2 requires
633.2659.
4.2.10. Ethyl 2-{[200-(2000-{2000 0-[bis(2000 00-ethoxy-2000 00-oxoethyl)amino]-
5000 0-formyl-4000 0-(prop-2 000000-en-1000 000-yloxy)phenoxy}ethoxy)phe-
nyl](20-ethoxy-20-oxoethyl)amino}acetate 12. Allyl bromide
(6.90 ml, 79.52 mmol, 4.0 equiv) was added to a stirred suspension
of phenol 11 (12.58 g, 19.88 mmol), K2CO3 (10.99 g, 79.52 mmol,
4.0 equiv) and KI (3.30 g, 19.88 mmol, 1.0 equiv) in DMF (100 ml).
The suspension was heated to 100 C overnight under an atmo-
sphere of argon. After cooling to rt the suspension was acidified to
pH 1 with 1M hydrochloric acid and extracted onto EtOAc
(2150 ml). The combined organic layers were washed with brine
(3300 ml), dried over magnesium sulfate and concentrated under
vacuum. The resulting residue was passed though a large plug of
silica eluting EtO2 then concentrated under vacuum. The residue
was then recrystallised from EtO2:Hexane to give allyl ether 12 as off
white solid (11.08 g, 83%). mp 95e96 C. dH (500MHz: CDCl3): 10.27
(1H, s, CHO), 7.27 (1H, s, H-6), 6.89e6.79 (4H, m, AreH), 6.26 (1H, s,
H-3), 6.01 (1H, ddd, J¼17.2, 10.5, 5.2 Hz, CH]CH2), 5.40 (1H, ddd,
J¼17.3, 3.0, 1.5 Hz, CH¼CHAHB), 5.31 (1H, dq, J¼10.5, 1.3 Hz,
CH¼CHAHB), 4.56 (2H, dt, J¼5.2, 1.5 Hz, OCH2), 4.25e4.21 (4H, m,
OCH2CH2O), 4.21 (4H, s, 2NCH2), 4.13 (4H, s, 2NCH2), 4.06 (4H, q,
J¼7.1 Hz, 2CO2CH2), 4.04 (4H, q, J¼7.1 Hz, 2CO2CH2), 1.15 (6H, t,
J¼7.1 Hz, 2CH3),1.13 (6H, t, J¼7.1 Hz, 2CH3). dC (126MHz: CDCl3):
187.42 (CH), 171.45 (C), 170.66 (C), 157.32 (C), 150.12 (C), 146.39 (C),
143.80 (C), 139.39 (C), 132.70 (CH), 122.02 (CH), 121.57 (CH), 118.99
(CH), 117.92 (CH2), 117.75 (C), 113.20 (CH), 110.55 (CH), 102.25 (CH),
69.81 (CH2), 67.54 (CH2), 66.83 (CH2), 61.16 (CH2), 60.69 (CH2),
53.83 (CH2), 53.42 (CH2), 14.00 (CH3), 13.94 (CH3).m/z (ESI): Found:
695.2773. C34H44O12N2 requires (MþNa)þ, 695.2786. ymax (ATR)/
cm1: 2987 (CH), 2868 (CH), 1745 (CO2), 1732 (CHO), 1666 (C]C).
4.2.11. Synthesis of nitroaryl 13. Fuming nitric acid (0.10 ml of
a stock solution in dichloromethane (0.11 ml in 1.0 ml)) was added
slowly to a stirred solution of aldehyde 12 (165 mg, 0.24 mmol,
1.0 equiv) and acetic acid (0.2 ml) in dry dichloromethane (2.0 ml)
at 0 C under argon. The resulting deep red coloured solution was
stirred at 0 C for 45 min then pour into aqueous potassium car-
bonate. The product was extracted with dichloromethane
(210 ml) and the combined organics washed with brine
(250ml). The organic layer was dried over magnesium sulfate and
concentrated under vacuum. The resulting residue was purified by
column chromatography on silica elution EtOAc:Hexane 1:1 to give
aldehyde 13 as a bright yellow solid (100 mg, 57%). mp 125e126 C.
dH (500 MHz: CDCl3): 10.27 (1H, s, CHO), 7.82 (1H, dd, J¼9.0, 2.5 Hz,
H-4), 7.69 (1H, d, J¼2.5 Hz, H-6), 7.28 (1H, s, H-60), 6.68 (1H, d,
J¼9.0 Hz, H-3), 6.28 (1H, s, H-30), 6.02 (1H, ddt, J¼17.2, 10.5, 5.2 Hz,
CH]CH2), 5.39 (1H, ddd, J¼17.3, 3.0, 1.5 Hz, CH¼CHAHB), 5.30 (1H,
ddd, J¼10.6, 2.6, 1.3 Hz, CH¼CHAHB), 4.55 (2H, dt, J¼5.2, 1.4 Hz,
OCH2), 4.28e4.26 (2H, m, OCH2CH2O), 4.25e4.23 (2H, m, OCH2-
CH2O), 4.20 (4H, s, 2NCH2), 4.19 (4H, s, 2NCH2), 4.12e4.07 (8H,
m, 4CO2CH2), 1.17 (12H, t, J¼7.1 Hz, 4CH3). dC (126 MHz: CDCl3):187.32 (CH), 170.50 (C), 170.30 (C), 157.54 (C), 148.45 (C), 146.50 (C),
145.50 (C), 143.60 (C), 140.79 (C), 132.67 (CH), 118.42 (CH), 117.99
(CH2), 117.90 (C), 115.94 (CH), 111.20 (CH), 108.10 (CH), 102.53 (CH),
69.85 (CH2), 67.59 (CH2), 67.27 (CH2), 61.30 (CH2), 61.17 (CH2), 53.91
(CH2), 53.83 (CH2), 14.04 (CH3), 14.00 (CH3). m/z (FAB): 717.4
((MþH)þ, 70%), 644.2 (100), 599.2 (40), 392.2 (70). Found: 717.2748.
C34H43O14N3 requires (MþH)þ, 717.2745. ymax (ATR)/cm1: 2982
(CH), 2939 (CH), 1737 (CO2), 1730 (CHO), 1662 (C]C), 1518 (CNO2),
1327 (CNO2).
4.2.12. Synthesis of benzofuran 14. Osmium tetroxide (47 ml,
0.007 mmol, 0.03 equiv, 4% solution in water) was added to a so-
lution of allyl ether 13 (179 mg, 0.249 mmol), sodium periodate
(213 mg, 0.996 mmol, 4.0 equiv) and 2,6-lutidine (56 ml,
0.498 mmol, 2.0 equiv) in dioxane:water (3:1) (4 ml). The solution
was stirred under argon at rt overnight. The resulting bright yellow
solutionwas extracted into EtOAc (220ml). The combined organic
layers werewashedwith brine (250ml) and 1MHCl (50ml) dried
over magnesium sulfate and concentrated under vacuum. The
residue was dissolved in acetic acid (2 ml) then heated to 90 C
under argon for 1 h. After cooling the solutionwas neutralised with
saturated sodium bicarbonate solution and extracted into EtOAc
(220 ml). The combined organic layer was washed with brine
(230 ml), dried over magnesium sulfate and concentrated under
vacuum. The residue was recrystallised twice from MeOH to give
benzofuran 14 as a bright yellow solid (34 mg, 19% over two steps).
mp 154e155 C. dH (500 MHz: CDCl3): 9.71 (1H, s, CHO), 7.83 (1H,
dd, J¼8.9, 2.5 Hz, H-4), 7.73 (1H, d, J¼2.5 Hz, H-6), 7.42 (1H, d,
J¼0.6 Hz, H-30 Furan ring), 7.10 (1H, s, H-40), 6.97 (1H, s, H-70), 6.70
(1H, d, J¼9.0, H-3), 4.36e4.30 (4H, m, OCH2CH2O), 4.22 (4H, s,
2NCH2), 4.20 (4H, s, 2NCH2), 4.09 (4H, q, J¼7.1 Hz, 4CO2CH2),
4.06 (4H, q, J¼7.1 Hz, 2CO2CH2), 1.18 (6H, t, J¼7.1 Hz, 2CH3), 1.14
(6H, t, J¼7.1 Hz, 2CH3). dC (126 MHz: CDCl3): 178.43 (CH), 170.67
(C), 170.35 (C), 152.89 (C), 152.61 (C), 148.82 (C), 148.55 (C), 145.35
(C), 143.11 (C), 140.93 (C), 120.07 (C), 118.40 (CH), 180.08 (CH),116.11
(CH), 108.10 (CH), 105.84 (CH), 101.67 (CH), 67.65 (CH2), 67.63 (CH2),
61.25 (CH2), 61.07 (CH2), 53.83 (CH2), 14.04 (CH3), 13.97 (CH3). m/z
(EI): 701.1 (Mþ, 40%), 628.1 (100), 600.1 (15). Found: 701.2431.
C33H39O14N3 requires (Mþ), 701.2432. ymax (ATR)/cm1: 2983 (CH),
2937 (CH), 1739 (CO2), 1514 (CNO2), 1329 (CNO2).
4.2.13. Synthesis of thiohydantoin 16. Thiocarbonyl diimidazole
(5.87 g, 32.96 mmol, 1.1 equiv) was added to a solution of 1-amino-
3-azidopropane37 15 (3.00 g, 29.96 mmol, 1.0 equiv) in dry CHCl3
(50 ml) at 0 C. The solution was warmed to rt and stirred at rt for
a further three hours. After this time glycine methyl ester hydro-
chloride (4.51 g, 35.95 mmol, 1.2 equiv) and triethylamine (5.0 ml,
35.95 mmol, 1.2 equiv) were added and the solution heated to 70 C
overnight under an atmosphere of argon. After cooling the solution
was washed with 1MHCl (2100ml) dried over sodium sulfate and
concentrated under vacuum. The deep purple residue was passed
through a plug of silica elution EtOAc:Petroleum ether to give thi-
ohydantoin 16 as a orange solid (2.84 g, 47%). mp 62e65 C. dH
(500MHz: CDCl3): 7.30 (1H, broad s, NH), 4.10 (2H, s, CH2), 3.92 (2H,
t, J¼7.0 Hz, NCH2), 3.39 (2H, t, J¼6.6 Hz, N3CH2), 2.01e1.93 (2H, m,
CH2CH2CH2). dC (126 MHz: CDCl3): 184.79 (C), 171.44 (C), 49.02
(CH2), 48.38 (CH2), 38.85 (CH2), 27.03 (CH2). m/z (CI): 200.0
((MþH)þ, 100%), 157.0 (MN3, 100). Found: 200.0603. C6H9ON5S
requires (MþHþ), 200.0606. ymax (ATR)/cm1: 3219 (NH), 2928
(CH), 2090 (N3), 1705 (NCO), 1516 (NCS).
4.2.14. Synthesis of NitroAzidoFuraRed tetraethyl ester
17. Piperidine (1 drop) was added to a solution benzofuran 14
(56 mg, 0.079 mmol) and thiohydantoin 16 (24 mg, 0.119 mmol,
1.5 equiv) in EtOH (3 ml). The deep red coloured solution was
heated to 70 C overnight under an atmosphere of argon. After
S.T. Caldwell et al. / Tetrahedron 71 (2015) 9571e9578 9577cooling the resulting solid filtered and washed with EtOH to give
the azide 17 a bright red solid (47 mg, 67%). mp 162e165 C. dH
(500MHz: CDCl3): 9.40 (1H, s, NH), 7.85 (1H, dd, J¼8.9, 2.4 Hz, H-4),
7.73 (1H, d, J¼2.4 Hz, H-6), 7.03 (1H, d, J¼0.6 Hz, H-70), 7.01 (1H, s,
H-40), 6.92 (1H, s, H-30 Furan ring), 6.69 (1H, d, J¼8.9, H-3), 6.56 (1H,
s, CH]C), 4.37e4.30 (4H, m, OCH2CH2O), 4.23 (4H, s, 2NCH2), 4.22
(4H, s, 2NCH2), 4.12 (4H, q, J¼7.2 Hz, 4CO2CH2), 4.07 (4H, q,
J¼7.1 Hz, 2CO2CH2), 4.05e4.01 (2H, m, NCH2), 3.41 (2H, t,
J¼6.6 Hz, CH2N3), 2.06e1.99 (2H, m, CH2CH2CH2), 1.21 (6H, t,
J¼7.1 Hz, 2CH3),1.15 (6H, t, J¼7.1 Hz, 2CH3). dC (126MHz: CDCl3):
176.09 (C), 170.79 (C), 170.39 (C), 163.23 (C), 152.18 (C), 150.95 (C),
148.59 (C), 148.54 (C), 145.34 (C), 141.05 (C), 140.90 (C), 124.44 (C),
121.75 (C), 118.39 (CH), 116.05 (CH), 112.88 (CH), 108.10 (CH), 105.15
(CH), 101.59 (CH), 100.23 (CH), 67.66 (CH2), 61.27 (CH2), 61.09 (CH2),
53.83 (CH2), 48.97 (CH2), 38.84 (CH2), 27.26 (CH2), 14.05 (CH3),
13.99 (CH3). m/z (ESI): 905.2702 (MþNa)þ, 756.2500, 724.2245.
Found: 905.2623. C39H46O14N8S requires ((MþNa)þ), 905.2746.
ymax (ATR)/cm1: 3315 (NH), 2978 (CH), 2939 (CH), 2098 (N3), 1745
(CO2), 1716 (C]O), 1510 (CNO2).
4.2.15. Synthesis of NitroAzidoFuraRed. Potassium hydroxide
(0.3 ml of a 0.5M solution) was added to a suspension of tetraethyl
ester 17 (7.6 mg, 8.6 mmol) in dioxane (1 ml). The solution was
stirred at rt under an atmosphere of argon and shielded from the
light for 3 h then water (1 ml) was added and the solution stirred
for a further 1 h. After this time the red coloured solution was
further diluted with water (15 ml), acidified with 1M hydrochloric
acid and extracted into EtOAc (210 ml). The combined organic
layers were then washed with brine (230 ml), dried over sodium
sulfate and concentrated under vacuum to give the tetraacid
NitroAzidoFuraRed as a red coloured solid (5.7 mg, 86%). dH
(400 MHz: D-3 MeCN): 10.11 (1H, s, NH), 7.85 (1H, dd, J¼9.0, 2.5 Hz,
H-4), 7.78 (1H, d, J¼2.5 Hz, H-6), 7.28 (1H, s, H-70), 7.17 (1H, s, H-40),
7.11 (1H, s, H-30 Furan ring), 6.81 (1H, d, J¼9.0, H-3), 6.59 (1H, s,
CH]C), 4.43e4.39 (2H, m, OCH2CH2O), 4.37e4.32 (2H, m, OCH2-
CH2O), 4.25 (4H, s, 2NCH2), 4.17 (4H, s, 2NCH2), 3.97 (2H, t,
J¼6.8 Hz, NCH2), 3.44 (2H, t, J¼6.6 Hz, CH2N3), 1.96 (presumed 2H,
m, obscured by MeCN). HRMS obtained on NitroAzidoFuraRed-
FFKDEL derivative below.
4.2.16. Synthesis of azide 18. Benzaldehyde (0.13 ml, 1.3 mmol,
1.3 equiv) and piperidine (2 drops) were added to a solution of
thiohydantoin 16 (200 mg, 1.00 mmol) in EtOH (3 ml). The solution
was heated to 70 C for 4 h under an atmosphere of argon. After
cooling to rt the solvent was removed under vacuum and the res-
idue purified by column chromatography on a 10 g SNAP ultra
cartridge eluting 100% hexane increasing to 30% EtOAc/70% Hexane
to give the azide as a bright yellow solid (252 mg, 88%). mp
92e96 C. dH (500 MHz: CDCl3): 8.93 (1H, broad s, NH), 7.49e4,39
(5H, m, AreH), 6.76 (1H, s, CH), 4.01 (2H, t, J¼7.0 Hz, NCH2), 3.40
(2H, t, J¼6.7 Hz, N3CH2), 2.01 (2H, quin, J¼6.8 Hz, CH2). dC (126MHz:
CDCl3): 177.92 (C), 163.63 (C), 132.66 (C), 129.86 (CH), 129.51 (CH),
129.10 (CH), 126.20 (C), 113.76 (CH), 48.92 (CH2), 38.91 (CH2), 27.19
(CH2). m/z (ESI): 310.0721 (MþNa)þ. Found: 310.0721. C13H13ON5-
SNa requires ((MþNa)þ), 310.0733. ymax (ATR)/cm1: 3342 (NH),
2947 (CH), 2096 (N3), 1712 (NCO), 1464 (NCS).
4.2.17. Synthesis of azide 19. Potassium carbonate (326 mg,
2.35 mmol, 1.5 equiv) was added to a solution of bromomethyl
acetate (0.23 ml, 2.35 mmol, 1.5 equiv) and azide 18 (450 mg,
1.57 mmol) in DMF (6 ml). The solution was stirred at rt overnight,
diluted with water (30 ml) and extracted twice into EtOAc (15 ml).
The combined organic layer was washed with brine (330 ml),
dried over magnesium sulfate and concentrated under vacuum. The
residue was purified by column chromatography on silica eluting
EtOAc:Hexane 1:2 to give the azide as a pale brown solid (240 mg,42%). mp 70e74 C. dH (500 MHz: CDCl3): 8.14e8.12 (2H, m, AreH),
7.42e4,34 (3H, m, AreH), 7.00 (1H, s, CH), 5.91 (2H, s, OCH2), 3.63
(2H, t, J¼6.9 Hz, NCH2), 3.34 (2H, t, J¼6.5 Hz, N3CH2), 2.12 (3H, s,
CH3),1.87 (2H, quin, J¼6.8 Hz, CH2). dC (126MHz: CDCl3): 170.45 (C),
169.57 (C), 161.60 (C), 137.48 (C), 133.91 (C), 131.95 (CH), 130.03
(CH),128.58 (CH),125.40 (CH), 61.55 (CH2), 48.37 (CH2), 38.12 (CH2),
28.03 (CH2), 20.59 (CH3). m/z (EI): 359.3 (Mþ, 8%), 276.2 (30), 204.1
(100). Found: 359.1055. C16H17O3N5S requires (Mþ), 359.1052. ymax
(ATR)/cm1: 3026 (CH), 2943 (CH), 2098 (N3), 1747 (CO2), 1710
(NCO), 1494 (NCS).
4.2.18. Synthesis of alkyne 20. DMAP, (56 mg, 0.46 mmol, 0.1 equiv)
was added to a solution of EDCI (1.15 g, 6.00 mmol, 1.3 equiv), 4-
pentynoic acid (500 mg, 5.10 mmol, 1.1 equiv) and L-phenylala-
nine methyl ester hydrochloride (1.00 g, 4.62 mmol) in dry CH2Cl2
(20 ml). After stirring at rt overnight under argon the solution was
diluted with CH2Cl2 (10 ml), washed with 1M HCl (30 ml) then
saturated NaHCO3 solution (30 ml). The solution was dried ove
magnesium sulfate and concentrated under vacuum to give the
alkyne as a white solid (698 mg, 58%). mp 88e90 C. dH (500 MHz:
CDCl3): 7.32e7.24 (3H, m, AreH), 7.13e7.11 (2H, m, AreH), 6.15 (1H,
d, J¼7.7 Hz, NH), 4.92 (1H, dt, J¼7.8, 5.8 Hz, CH), 3.74 (3H, s, OMe),
3.18 (1H, dd, J¼13.9, 5.8 Hz, CHAHB), 3.11 (1H, dd, J¼13.9, 5.8 Hz,
CHAHB), 2.53e2.49 (2H, m, CH2), 2.44e2.39 (2H, m, CH2), 1.98 (1H, t,
J¼2.6 Hz, CH). dC (126MHz: CDCl3): 171.90 (C),170.37 (C),135.74 (C),
129.23 (CH), 128.51 (CH), 127.08 (CH), 82.72 (C), 69.33 (CH), 53.10
(CH), 52.27 (CH3), 37.83 (CH2), 35.08 (CH2), 14.61 (CH2). m/z (EI):
259.2 (Mþ, 5%), 200 (15), 162.1 (100). Found: 259.1206. C15H17O3N
requires (Mþ), 259.1208. ymax (ATR)/cm1: 3309 (Alkyne), 3252
(NH), 1720 (CO2), 1643 (CON).
4.2.19. Synthesis of triazole 21. Tetrakis(acetonitrile)copper(I) hex-
afluorophosphate (12 mg, 0.033 mmol, 0.2 equiv) was added to
a solution of azide 19 (60 mg, 0.167 mmol, 1.0 equiv) and alkyne 20
(130 mg, 0.50 mmol, 3.0 equiv) in degassed DMSO (1 ml). The so-
lution was heated to 60 C for 1 h. After cooling the solution was
quenched with water (25 ml) and extracted twice with CH2Cl2
(8 ml). The combined organic layers were washed twice with brine
(20ml), dried over sodium sulfate and concentrated under vacuum.
The residue was purified by column chromatography on a 10 g
SNAP ultra cartridge eluting 100% CH2Cl2 increasing to CH2Cl2:6%
MeOH to give the triazole as a pale yellow viscous oil (83 mg, 80%).
dH (500 MHz: CDCl3): 8.15e8.13 (2H, m, AreH), 7.50 (1H, s, CH),
7.45e7.38 (3H, m, AreH), 7.28e7.20 (3H, m, AreH), 7.07e7.05 (2H,
m, AreH), 7.01 (1H, s, PhCH), 6.40 (1H, d, J¼7.8 Hz, NH), 5.90 (2H, s,
OCH2), 4.86 (1H, dt, J¼7.8, 6.1 Hz, NHCH), 4.33 (2H, t, J¼6.9, NCH2),
3.69 (3H, s, OMe), 3.60 (2H, t, J¼6.8, NCH2), 3.12 (1H, dd, J¼13.9,
5.7 Hz, CHAHB), 3.06e3.01 (3H, m, CHAHBþCOCH2CH2), 2.61 (2H, t,
J¼7.3, COCH2CH2), 2.25 (2H, quin, J¼6.8 Hz, CH2CH2CH2), 2.13 (3H, s,
CH3). dC (126 MHz: CDCl3): 171.87 (C), 171.48 (C), 170.57 (C), 169.74
(C), 161.30 (C), 146.45 (C), 137.34 (C), 135.83 (C), 133.83 (C), 132.04
(CH), 130.23 (CH), 129.04 (CH), 128.61 (CH), 128.41 (CH), 126.91
(CH), 125.82 (CH), 121.77 (CH), 61.58 (CH2), 53.06 (CH), 52.12 (CH3),
47.14 (CH2), 37.80 (CH2), 37.66 (CH2), 35.34 (CH2), 29.46 (CH2), 21.18
(CH2), 20.62 (CH3). m/z (ESI): 641.2137 (MþNa)þ. Found: 641.2137.
C31H34O6N6S requires ((MþNa)þ), 641.2153. ymax (ATR)/cm1: 3300
(NH), 3252 (NH), 1743 (CO2), 17,414 (CO2), 1664 (CON).
4.2.20. Synthesis of NitroFuraRed-FFKDEL penta-AM. Hunig’s base
(0.1 ml, 0.57 mmol, 112 equiv) and bromomethyl acetate (0.1 ml,
1.02 mmol, 204 equiv) were added to a solution of Nitro-
AzidoFuraRed (3.9 mg, 0.005 mmol) in dry MeCN (1 ml). The so-
lution was stirred at rt overnight, diluted with CH2Cl2 (7 ml),
washed with 0.5M HCl (10 ml), dried over magnesium sulfate and
concentrated under vacuum. The residue was purified by column
chromatography on silica eluting EtO2:CHCl3 (1:1) to give the
S.T. Caldwell et al. / Tetrahedron 71 (2015) 9571e95789578product as a deep red solid, which was used without further pu-
rification. Tetrakis(acetonitrile)copper(I) hexafluorophosphate
(w0.3 mg, 0.0008 mmol, 0.5 equiv) was added to a solution of
crude azide obtained from the above AM protection (2 mg,
0.0017 mmol, 1.0 equiv) and alkyne ((4-Pentynoyl-NH)-FFKDEL-
COOH) (Eurogentec, Belgium) (4.7 mg, 0.0053 mmol, 3.0 equiv) in
degassed DMSO (0.5 ml). The solution was heated to 70 C under
argon for 1 h, cooled to rt and diluted with water (5 ml) then
extracted with CH2Cl2 (25 ml). The combined organic layers were
concentrated under vacuum and the residue purified by prep-HPLC
carried out on a Spectrasystem P2000 using a 250 mm21.2 mm
Gemini-NX 10 micron C-18 column maintained at 25 C and eluted
0.1% TFA (90%):acetonitrile (10%) for 10 min followed by a 10e80%
gradient at 15 ml/min over a further 40 min. The product con-
taining fractions were concentrated under vacuum to give the tri-
azole as a red solid (1.5 mg, 42%). The compound was characterised
by LCMS (see ESI).
Acknowledgements
We thankWellcome Trust (WT092292/B/10/Z, WT092292MA, &
WT092292/Z/10/Z), BBSRC (BB/D526310/1) and British Heart
Foundation (PG/11/70/29086) for funding.
Supplementary data
Supplementary data (NMR spectra and ESI data) associated with
this article can be found in the online version, at http://dx.doi.org/
10.1016/j.tet.2015.10.052.
References and notes
1. (a) Bading, H. Nat. Rev. Neurosci. 2013, 14, 593e608; (b) Fu, S.; Watkins, S. M.;
Hotamisligil, G. S. Cell Metab. 2012, 15, 623e634; (c) Catterall, W. A. Cold Spring
Harbor Perspectives in Biology, 2011, Vol. 3, p a003947; (d) Rasola, A.; Bernardi, P.
Cell Calcium 2011, 50, 222e233.
2. (a) Becker, P. L.; Singer, J. J.; Walsh, J. V., Jr.; Fay, F. S. Science 1989, 244, 211e214;
(b) McCarron, J. G.; McGeown, J. G.; Reardon, S.; Ikebe, M.; Fay, F. S.; Walsh, J. V.,
Jr. Nature 1992, 357, 74e77.
3. (a) McCarron, J. G.; Chalmers, S.; Bradley, K. N.; Macmillan, D.; Muir, T. C. Cell
Calcium 2006, 40, 461e493; (b) Rizzuto, R.; Pozzan, T. Physiol. Rev. 2006, 86,
369e408.
4. ZhuGe, R.; Tuft, R. A.; Fogarty, K. E.; Bellve, K.; Fay, F. S.; Walsh, J. V., Jr. J. Gen.
Physiol. 1999, 113, 215e228.
5. Reviews of Ca2þ imaging: (a) Grienberger, C.; Konnerth, A. Neuron 2012, 73,
862e885; (b) Russell, J. T. Brit. J. Pharmacol. 2011, 163, 1605e1625.
6. Imaging Ca2þ using nanoparticles: Kantner, K.; Ashraf, S.; Carregal-Romero, S.;
Carrillo-Carrion, C.; Collot, M.; del Pino, P.; Heimbrodt, W.; De Aberasturi, D. J.;
Kaiser, U.; Kazakova, L. I.; Lelle, M.; de Baroja, N. M.; Montenegro, J. M.; Naz-
arenus, M.; Pelaz, B.; Peneva, K.; Gil, P. R.; Sabir, N.; Schneider, L. M.; Shabar-
china, L. I.; Sukhorukov, G. B.; Vazquez, M.; Yang, F.; Parak, W. J. Small 2015, 11,
896e904.
7. Imaging Ca2þ using genetically encoded sensors: Partrodge, J. G. Front. Phar-
macol. 2015, 6, 42, http://dx.doi.org/10.3389/fphar.2015.00042
8. Tsien, R. Y. Biochemistry 1980, 19, 2396e2404.
9. Grynkiewicz, G.; Poenie, M.; Tsien, R. Y. J. Biol. Chem. 1985, 260, 3440e3450.
10. Paredes, R. M.; Etzler, J. C.; Watts, L. T.; Zheng, W.; Lechleiter, J. D.Methods 2008,
46, 143e151.
11. The Molecular Probes Handbook: A Guide to Fluorescent Probes and Labelling
Technologies, 11th ed.; Johnson, I., Spence, M. T. Z., Eds.; Life Technologies Cor-
poration: 2010, Chapter 19.
12. Duan, W.; Wei, H.; Cui, T.; Gao, B. J. Mater. Chem. B 2015, 3, 894e898.
13. (a) Liu, Q.; Du, H.; Ren, X.; Bian, W.; Fan, L.; Shuang, S.; Dong, C.; Hu, Q.; Choi,
M. M. F. Anal. Chem. 2014, 86, 8025e8030; (b) Liu, Q.; Bian, W.; Shi, H.; Fan, L.;
Shuang, S.; Dong, C.; Choi, M. M. F. Org. Biomol. Chem. 2013, 11, 503e508.14. Egawa, T.; Hanaoka, K.; Koide, Y.; Ujita, S.; Takahashi, N.; Ikegaya, Y.; Matsuki,
N.; Terai, T.; Ueno, T.; Komatsu, T.; Nagano, T. J. Am. Chem. Soc. 2011, 133,
14157e14159.
15. Egawa, T.; Hirabayashi, K.; Koide, Y.; Kobayashi, C.; Takahashi, N.; Mineno, T.;
Terai, T.; Ueno, T.; Komatsu, T.; Ikegaya, Y.; Matsuki, N.; Nagano, T.; Hanaoka, K.
Angew. Chem., Int. Ed. 2013, 52, 3874e3877.
16. Collot, M.; Loukou, C.; Yakovlev, A. V.; Wilms, C. D.; Li, D.; Evrard, A.; Zamaleeva,
A.; Bourdieu, L.; Leger, J.-F.; Ropert, N.; Eilers, J.; Oheim, M.; Feltz, A.; Mallet, J.-
M. J. Am. Chem. Soc. 2012, 134, 14923e14931.
17. Matsui, A.; Umezawa, K.; Shindo, Y.; Fujii, T.; Citterio, D.; Oka, K.; Suzuki, K.
Chem. Commun. 2011, 10407e10409.
18. Review: Oheim, M.; van ’t Hoff, M.; Feltz, A.; Zamaleeva, A.; Mallet, J.-M.; Collot,
M. Biochim. Biophys. Acta, Mol. Cell Res. 2014, 1843, 2284e2306.
19. Kikuchi, K. Chem. Soc. Rev. 2010, 39, 2048e2053.
20. Recent examples of dual excitation include: (a) Roesl, C.; Sato, K.; Schiemann,
A.; Pollock, N.; Stowell, K. M. Cell Calcium 2014, 56, 195e201; (b) Pavillon, N.;
Marquet, P. Methods Mol. Biol. (Clifton, N.J.) 2015, 1254, 21e32.
21. Typical examples of dual emission include: (a) Chandsawangbhuwana, C.; Shi,
L. Z.; Zhu, Q.; Berns, M. W. J. Biophot. 2014, 7, 571e579; (b) Brero, A.; Ramella, R.;
Fitou, A.; Dati, C.; Alloatti, G.; Gallo, M. P.; Levi, R. Cardiovasc. Res. 2010, 88,
443e452.
22. Original report: (a) Kurebayashi, N.; Harkins, A. B.; Baylor, S. M. Biophys. J. 1993,
64, 1934e1960; (b) DeMarinis, R. M.; Katerinopoulos, H. E.; Muirhead, K. A.
Fluorescent Intracellular Calcium Indicators. U.S.A. Patent 4,849,362, July 18,
1989.
23. Examples of ratiometric use include: (a) Dai, X. Q.; Fox, J. E. M.; Chikvashvili, D.;
Casimir, M.; Plummer, G.; Hajmrle, C.; Spigelman, A. F.; Kin, T.; Singer-Lahat, D.;
Kang, Y.; Shapiro, A. M. J.; Gaisano, H. Y.; Lotan, I.; MacDonald, P. E. Diabetologia
2012, 55, 1709e1720; (b) Rainbow, R. D.; MacMillan, D.; McCarron, J. G. Cell
Calcium 2009, 46, 313e322; (c) Lohr, C. Cell Calcium 2003, 34, 295e303.
24. Ilatovskaya, D. V.; Palygin, O.; Levchenko, V.; Staruschenko, A. Am. J. Physiol. Cell
Physiol. 2013, 305, C1050eC1059.
25. A lower Kd value of 140 nM at pH 7.2 has been reported by a commercial
supplier see reference 10.
26. Review: Patterson, D. M.; Nazarova, L. A.; Prescher, J. A. ACS Chem. Biol. 2014, 9,
592e605.
27. Gaillard, S.; Yakovlev, A.; Luccardini, C.; Oheim, M.; Feltz, A.; Mallet, J.-M. Org.
Lett. 2007, 9, 2629e2632.
28. Review of Hammett parameters: Hansch, C.; Leo, A.; Taft, R. W. Chem. Rev. 1991,
91, 165e195.
29. Lim, C. S.; Kang, M. Y.; Han, J. H.; Danish, I. A.; Cho, B. R. Chem.dAsian J. 2011, 6,
2028e2033.
30. (a) Ruggiu, A. A.; Bannwarth, M.; Johnsson, K. Org. Biomol. Chem. 2010, 8,
3398e3401; (b) Bannwarth, M.; Correa, I. R., Jr.; Sztretye, M.; Pouvreau, S.;
Fellay, C.; Aebischer, A.; Royer, L.; Rios, E.; Johnsson, K. ACS Chem. Biol. 2009, 4,
179e190.
31. Takei, Y.; Murata, A.; Yamagishi, K.; Arai, S.; Nakamura, H.; Inoue, T.; Takeoka, S.
Chem. Commun. 2013, 7313e7315.
32. Ji, X.; Cheng, B.; Song, J.; Liu, C.; Wang, Y. Synth. Commun. 2009, 39, 2053e2057.
33. Dong, X.; Yang, Y.; Sun, J.; Liu, Z.; Liu, B.-F. Chem. Commun. 2009, 3883e3885.
34. Klymchenko, A. S.; Ozturk, T.; Pivovarenko, V. G.; Demchenko, A. P. Tetrahedron
Lett. 2001, 42, 7967e7970.
35. Ma, Z. K.; Clark, R. F.; Brazzale, A.; Wang, S. Y.; Rupp, M. J.; Li, L. P.; Griesgraber,
G.; Zhang, S. M.; Yong, H.; Phan, L. T.; Nemoto, P. A.; Chu, D. T. W.; Plattner, J. J.;
Zhang, X. L.; Zhong, P.; Cao, Z. S.; Nilius, A. M.; Shortridge, V. D.; Flamm, R.;
Mitten, M.; Meulbroek, J.; Ewing, P.; Alder, J.; Or, Y. S. J. Med.Chem. 2001, 44,
4137e4156.
36. (a) Gressel, J.; Michaeli, D.; Kampel, V.; Amsellem, Z.; Warshawsky, A. J. Agr.
Food Chem. 2002, 50, 6353e6360; (b) Etter, E. F.; Kuhn, M. A.; Fay, F. S. J. Biol.
Chem. 1994, 269, 10141e10149.
37. Carboni, B.; Benalil, A.; Vaultier, M. J. Org. Chem. 1993, 58, 3736e3741.
38. Elokdah, H.; Sulkowski, T. S.; Abou-Gharbia, M.; Butera, J. A.; Chai, S. Y.;
McFarlane, G. R.; McKean, M. L.; Babiak, J. L.; Adelman, S. J.; Quinet, E. M. J. Med.
Chem. 2004, 47, 681e695.
39. Bulic, B.; Pickhardt, M.; Khlistunova, I.; Biernat, J.; Mandelkow, E.-M.; Man-
delkow, E.; Waldmann, H. Angew. Chem., Int. Ed. 2007, 46, 9215e9219.
40. Mironov, A. V.; Antipov, E. V.; Beloglazkina, E. K.; Majouga, A. G.; Krasnovskaya,
O. O.; Gerasimov, V. M.; Zyk, N. V. Russ. Chem. Bull. 2013, 62, 672e677.
41. Tsien, R. Y. Nature 1981, 290, 527e528.
42. Dancourt, J.; Barlowe, C. Annu. Rev. Biochem. 2010, 79, 777e802.
43. Wang, G.; Norton, A. S.; Pokharel, D.; Song, Y.; Hill, R. A. Nanomed. Nanotech.
Biol. Med. 2013, 9, 366e374; (c) Pap, E. H. W.; Dansen, T. B.; van Summeren, R.;
Wirtz, K. W. A. Exp. Cell Res. 2001, 265, 288e293.
44. Link, H.; Bernauer, K.; Englert, G. Helv. Chim. Acta 1982, 65, 2645e2667.
45. Baker, B. R.; Lourens, G. J. J. Med. Chem. 1968, 11, 26e32.
